ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone
August 27, 2020The notice confirms that SIR-Spheres® Y-90 resin microspheres meet the relevant requirements for drug registration in China. With this confirmation, Sirtex is approved to file a New Drug Application (NDA) in the country. -
Sirtex Medical gets unsolicited $1.41B counteroffer from Chinese investment firm
May 07, 2018Sirtex Medical, an Australian biotech, received an unsolicited $1.41 billion counteroffer from Chinese fund manager CDH Investments.The counteroffer by CDH is a nonbinding, indicative and conditional proposal for 100%
Pharma Sources Insight January 2025
